Clinical Professor Melissa Teo graduated from the National University of Singapore and completed her general surgical training in the Singapore General Hospital and National Cancer Centre Singapore. She was awarded the Singhealth Human Manpower Development Plan Award to pursue further training in complex abdominal and pelvic surgery. With a keen interest in treating and curing cancers, she completed two fellowships in surgical oncology and in colorectal surgery at the University of Toronto, Canada in 2009. Dr. Teo remains one of few accredited surgical oncologists in the country and region and is frequently consulted for her expertise in the management of gastrointestinal cancers, sarcomas and melanomas.

​​

Interested in health policies, she also obtained a Masters of Public Health from Johns Hopkins University, USA. She held many leadership positions whilst at the National Cancer Centre Singapore, including being the Head of the Division of Surgical Oncology. She also co-chaired the gastrointestinal oncology and was a member of the sarcoma, melanoma and cancer genetics Cancer Service Line development in SingHealth, prior to leaving the public service. Dr. Teo has authored over 130 peer-reviewed publications, 6 book chapters and won numerous teaching awards.

​

Dr. Teo is skilled in the management of stomach and colorectal cancers, sarcoma, melanoma and peritoneal disease. She is the first President of the Asian Peritoneal Surface Malignancy Group with her vast experience in Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS and HIPEC) for the treatment of peritoneal disease.

​

Dr. Teo's personal belief is that the management of cancer needs to be holistic, from early accurate detection and diagnosis to excellent surgical standards and multidisciplinary care and most importantly to being committed to caring for her patients and their families.